Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3886-3890

  Bièche, Ivan ^a   Tomasetto, Catherine ^b   Régnier, Catherine H ^b   Moog Lutz, Christel ^b   Rio, Marie Christine ^b   Lidereau, Rosette ^a  

^a CENTRE RENÉ HUGUENIN   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; BREAST CANCER; CHROMOSOME 17Q; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL;

BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; LEUKOCYTES; ONCOGENES; RECEPTOR, ERBB-2;

EID: 0029818173     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gebhart, E , Bruderlein, S., Augustus, M., Sieben, E., Feldner, J , and Schmidt, W. Cytogenetic studies on human breast carcinomas. Breast Cancer Res Treat , 8: 125-138, 1986.
2. Dutrillaux, B., Gerbault-Seureau, M., and Zafrani, B. Characterisation of chromosomal anomalies in human breast cancer' a comparison of 30 paradiploid cases with few chromosome changes Cancer Genet Cytogenet., 49: 203-217, 1990.
3. Guan, X. Y , Meltzer, P. S., Dalton, W. S., and Trent, J M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection Nat Genet., 8 155-161, 1994.
4. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfroy, B., and Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer. 10: 160-170, 1994
5. Bièche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
6. Kallioniemi, O., Kallioniemi, A., Waldman, F , Chen, L , Smith, H. S., Pinkel, D., and Gray, J. W. ERBB2 amplification in breast cancer analysed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
7. Slamon, D J , Clark, G. M , Wong, S. G., Levin, W. S , Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
8. Ravdin, P. M., and Chamness, G C. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene (Amst.), 159: 19-27, 1995
9. Dougall, W. C., Quian, X., Peterson, N. C , Miller, M. J., Samanta, A., and Greene, M I. The neu oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9: 2109-2123, 1994
10. Di Fiore, P. P., Pierce, J. H , Kraus, M. H., Segatto, O , King, C. R., and Aaronson, S. A ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science (Washington DC), 237: 178-182, 1987
11. Muller, W. J , Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated neu oncogene. Cell, 54 105-115, 1988.
12. Tomasetto, C , Régnier, C., Moog-Lutz, C., Mattei, M. G., Chenard, M. P., Lidereau, R., Basset, P., and Rio, M. C Identification of four novel human genes amplified and overexpressed in breast carcinoma and located to the q11-q21.3 region of chromosome 17, Genomics, 28: 367-376, 1995.
13. Régnier, C. H., Tomasetto, C., Moog-Lutz, C , Chenard, M. P , Wendling, C., Basset, P., and Rio, M C. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma J. Biol Chem , 270: 25715-25721, 1995
14. Tomasetto, C , Moog-Lutz, C., Régnier, C., Schreiber, V., Basset, P., and Rio, M. C. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett, 373 245-249, 1995.
15. Wilson, J. T., Wilson, L. B , de Riel, J. K , Villa-Komaroff, L , Efstratiadis, A., Forget, B. G , and Neissman, S. M. Insertion of synthetic copies of human globin genes into bacterial plasmids Nucleic Acids Res., 5: 563-581, 1978.
16. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F , Krust, A., and Chambon, P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast-cancer cell line. Nucleic Acids Res., 10: 7895-7903, 1982.
17. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning. A Laboratory Manual, pp. 458-462. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982
18. Auffray, C., and Rougeon, F Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA Eur. J. Biochem., 107: 303-314, 1980
19. Brookes, S., Lammie, G. A., Schuuring, E., de Boer, C , Michalides, R., Dickson, C., and Peters, G. Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1. Genes Chromosomes Cancer, 6 222-231, 1993.
20. Karlseder, J., Zeillinger, R., Schneeberger, C , Czerwenka, K., Speiser, P., Kubista, E., Birnbaum, D., Gaudray, P., and Theillet, C. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer Genes Chromosomes Cancer, 9: 42-48, 1994.
21. Reifenberger, G., Reifenberger, J., Ichimura, K , Meltzer, P. S., and Collins, V. P. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas' preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res., 54: 4299-4303, 1994.
22. Ali, I. U., Campbell, G , Lidereau, R , and Callahan, R. Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma Oncogene Res., 3: 139-146, 1988
23. Borg, A., Baldetorp, B., Ferno, M., Killander, D., Olsson, H., and Sigurdsson, H. ErbB2 amplification in breast cancer with a high rate of proliferation Oncogene, 6: 137-143, 1991.
24. Paterson, M. C., Dietrich, K. D , Danyluk, J., Paterson, A. H G , Lees, A. W., Jamil, N., Hanson, J., Jenkins, H., Krause, B. E , McBlain, W. A , Slamon, D. J., and Fourney, R. M. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer Cancer Res., 57: 556-567, 1991.
25. van de Vijver, M., Van de Bersselaar, R., Devilee, P , Coraelisse, C., Peterse, J , and Nusse, R. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene Mol Cell. Biol., 7: 2019-2023, 1987.
26. Keith, W. N., Douglas, F., Wishart, G. C , McCallum, H. M., George, W. D., Kaye, S. B., and Brown, R Co-amplification of erbB2. topoisomerase II α and retinoic acid receptor a genes m breast cancer and allelic loss at topoisomerase I on chromosome 20 Eur. J. Cancer, 29A 1469-1475, 1993.
27. Stein, D., Wu, J., Fuqua, S A W., Roonprapunt, C , Yajnik, V., D'Eustachio, P., Moskow, J. J , Buchberg, A. M., Osborne, C. K., and Margolis, B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J , 13: 1331-1340, 1994
28. Smith, K., Houlbrook, S., Greenall, M., Carmichael, J , and Harris, A L. Topoisomerase IIa co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Oncogene, 8: 933-938, 1993.